INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids

Hepatitis B Virus (HBV) reactivation in patients receiving chemotherapy, biologicals, immunosupressants, or corticosteroids is emerging to be an important cause of morbidity and mortality in patients with current or prior exposure to HBV infection. These patients suffer a dual onslaught of illness:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Exp Hepatol
Main Authors: Arora, Anil, Anand, Anil C., Kumar, Ashish, Singh, Shivaram P., Aggarwal, Rakesh, Dhiman, Radha K., Aggarwal, Shyam, Alam, Seema, Bhaumik, Pradeep, Dixit, Vinod K., Goel, Ashish, Goswami, Bhabadev, Kumar, Ashok, Kumar, Manoj, Madan, Kaushal, Murugan, Natarajan, Nagral, Aabha, Puri, Amarender S., Rao, Padaki N., Saraf, Neeraj, Saraswat, Vivek A., Sehgal, Sanjeev, Sharma, Praveen, Shenoy, Koticherry T., Wadhawan, Manav
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Clinical Practice Guideline
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286881/
https://ncbi.nlm.nih.gov/pubmed/30568345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.06.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados